- Triazolam, grapefruit juice, and prolonged sedation:
- CYP3A4 substrate triazolam potentiated by grapefruit/azoles/macrolides, flumazenil reversal with re-sedation monitoring, and LOT benzodiazepines that bypass CYP.
- Additive respiratory depression with benzodiazepine + opioid:
- Stacked CNS/respiratory depression, airway-first management, titrated naloxone + flumazenil, and prospective dose and monitoring rules.
- Diffusion hypoxia after nitrous oxide:
- NMDA antagonism mechanism, end-of-case 100% oxygen, contraindications (air-filled spaces), and chronic B12 inactivation in recreational abuse.
- Ketamine sedation and the emergence reaction:
- NMDA antagonism, sympathomimetic HR/BP rise, salivation, emergence reaction blunted by benzodiazepine premedication, and appropriate setting.
- Ethanol, metronidazole, and warfarin in the same patient:
- Disulfiram-like aldehyde-DH inhibition, metronidazole + warfarin INR rise, chronic ethanol + acetaminophen NAPQI, and benzodiazepine withdrawal first-line.
- Acute cocaine intoxication and the epinephrine caution:
- NE reuptake block, epi stacking → hypertensive crisis, defer elective work, vasoconstrictor-free LA when needed, and recovery patient management.
- Methamphetamine and 'meth mouth':
- Catecholamine release mechanism, multifactorial caries (xerostomia/bruxism/sugar), epi caution in acute use, and recovery-patient restorative plan.
- Acute cannabis intoxication chairside:
- CB1 agonism, tachycardia + dry mouth + anxiety, defer elective work + minimum epi for urgent care, and chronic-use xerostomia and gingival inflammation.
- Benzodiazepines and fall risk in an older adult:
- Beers criteria fall/fracture/confusion risk, start low + go slow + transport home, lorazepam phase II metabolism, iatrosedation + nitrous oxide alternatives.